1. Home
  2. ABEO vs HBB Comparison

ABEO vs HBB Comparison

Compare ABEO & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • HBB
  • Stock Information
  • Founded
  • ABEO N/A
  • HBB 1904
  • Country
  • ABEO United States
  • HBB United States
  • Employees
  • ABEO N/A
  • HBB N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • HBB Home Furnishings
  • Sector
  • ABEO Health Care
  • HBB Consumer Discretionary
  • Exchange
  • ABEO Nasdaq
  • HBB Nasdaq
  • Market Cap
  • ABEO 277.6M
  • HBB 292.6M
  • IPO Year
  • ABEO 1980
  • HBB 2017
  • Fundamental
  • Price
  • ABEO $5.86
  • HBB $20.27
  • Analyst Decision
  • ABEO Strong Buy
  • HBB
  • Analyst Count
  • ABEO 3
  • HBB 0
  • Target Price
  • ABEO $18.00
  • HBB N/A
  • AVG Volume (30 Days)
  • ABEO 292.3K
  • HBB 69.8K
  • Earning Date
  • ABEO 11-14-2024
  • HBB 10-30-2024
  • Dividend Yield
  • ABEO N/A
  • HBB 2.27%
  • EPS Growth
  • ABEO N/A
  • HBB 107.04
  • EPS
  • ABEO N/A
  • HBB 1.88
  • Revenue
  • ABEO N/A
  • HBB $647,834,000.00
  • Revenue This Year
  • ABEO N/A
  • HBB $4.60
  • Revenue Next Year
  • ABEO $7,097.06
  • HBB N/A
  • P/E Ratio
  • ABEO N/A
  • HBB $10.78
  • Revenue Growth
  • ABEO 147.52
  • HBB 5.30
  • 52 Week Low
  • ABEO $3.05
  • HBB $13.71
  • 52 Week High
  • ABEO $9.01
  • HBB $31.78
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 38.62
  • HBB 28.19
  • Support Level
  • ABEO $5.95
  • HBB $19.61
  • Resistance Level
  • ABEO $6.78
  • HBB $21.47
  • Average True Range (ATR)
  • ABEO 0.32
  • HBB 1.63
  • MACD
  • ABEO -0.07
  • HBB -0.54
  • Stochastic Oscillator
  • ABEO 7.07
  • HBB 6.55

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels.

Share on Social Networks: